Denmark’s Medicines Agency has approved Allocetra cell therapy from Israel’s Enlivex (see here previously) for Phase II clinical trials on patients with osteoarthritis in the knee. 40% of men and 47% of women develop knee osteoarthritis in their lifetimes. Allocetra also treats Covid and cancer.

https://enlivex.com/investors/news-releases/enlivex-receives-authorization-from-the-danish-medicines-agency-to-initiate-the-phase-ii-stage-of-its-phase-i-ii-trial-of-allocetra-in-patients-with-moderate-to-severe-knee-osteoarthritis/